arrow_back Trending Legislation
Share share

Funding research on valvular heart disease and increasing awareness

This new law increases funding for research into valvular heart diseases, including the causes of sudden cardiac arrest. It aims to improve diagnosis and treatment, and to raise public awareness of these conditions, potentially saving lives.
Key points
Increased funding for research into valvular heart diseases to better understand their causes and risk factors.
Activities aimed at increasing public awareness of valvular heart diseases and the risk of sudden cardiac death.
Workshops for experts to develop better methods for identifying and treating mitral valve prolapse.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Became Law
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Cardiovascular Advances in Research and Opportunities Legacy Act
Print number: HR 1193
Sponsor: Rep. Barr, Andy [R-KY-6]
Process start date: 2021-02-22
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Funding research on valvular heart disease and increasing awareness

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 1193.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-02-22.

What are the main provisions?

Key points include:

  • Increased funding for research into valvular heart diseases to better understand their causes and risk factors.
  • Activities aimed at increasing public awareness of valvular heart diseases and the risk of sudden cardiac death.
  • Workshops for experts to develop better methods for identifying and treating mitral valve prolapse.

What is the specific legal status?

The current status is Became Law.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Barr, Andy [R-KY-6].

What is the latest detailed status?

The latest detailed status is: Became Public Law No: 117-244.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

Analysis and Potential Impact of HR 1193

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health